nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Tamoxifen—pancreatic cancer	0.0678	0.0922	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0678	0.0922	CbGbCtD
Lercanidipine—CYP3A7—Irinotecan—pancreatic cancer	0.052	0.0708	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.052	0.0708	CbGbCtD
Lercanidipine—CYP3A5—Tamoxifen—pancreatic cancer	0.0508	0.0691	CbGbCtD
Lercanidipine—CYP3A5—Erlotinib—pancreatic cancer	0.0432	0.0588	CbGbCtD
Lercanidipine—CYP3A5—Irinotecan—pancreatic cancer	0.039	0.0531	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0381	0.0519	CbGbCtD
Lercanidipine—CYP3A7—Docetaxel—pancreatic cancer	0.0381	0.0519	CbGbCtD
Lercanidipine—CYP3A7—Sunitinib—pancreatic cancer	0.038	0.0516	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.038	0.0516	CbGbCtD
Lercanidipine—CYP2D6—Tamoxifen—pancreatic cancer	0.0312	0.0424	CbGbCtD
Lercanidipine—CYP3A5—Docetaxel—pancreatic cancer	0.0286	0.0389	CbGbCtD
Lercanidipine—CYP3A5—Sunitinib—pancreatic cancer	0.0285	0.0387	CbGbCtD
Lercanidipine—CYP2D6—Erlotinib—pancreatic cancer	0.0265	0.0361	CbGbCtD
Lercanidipine—CYP3A4—Tamoxifen—pancreatic cancer	0.0198	0.027	CbGbCtD
Lercanidipine—CYP3A4—Erlotinib—pancreatic cancer	0.0169	0.0229	CbGbCtD
Lercanidipine—CYP3A4—Irinotecan—pancreatic cancer	0.0152	0.0207	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—pancreatic cancer	0.0131	0.0178	CbGbCtD
Lercanidipine—CYP3A4—Docetaxel—pancreatic cancer	0.0112	0.0152	CbGbCtD
Lercanidipine—CYP3A4—Sunitinib—pancreatic cancer	0.0111	0.0151	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—pancreatic cancer	0.00831	0.0113	CbGbCtD
Lercanidipine—Nimodipine—AHR—pancreatic cancer	0.00252	1	CrCbGaD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000217	0.000827	CcSEcCtD
Lercanidipine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000217	0.000825	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000215	0.000821	CcSEcCtD
Lercanidipine—Anaemia—Docetaxel—pancreatic cancer	0.000215	0.000819	CcSEcCtD
Lercanidipine—Pancytopenia—Epirubicin—pancreatic cancer	0.000214	0.000814	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000212	0.00081	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000212	0.00081	CcSEcCtD
Lercanidipine—Vomiting—Sunitinib—pancreatic cancer	0.000212	0.000807	CcSEcCtD
Lercanidipine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000211	0.000805	CcSEcCtD
Lercanidipine—Neutropenia—Epirubicin—pancreatic cancer	0.00021	0.000802	CcSEcCtD
Lercanidipine—Rash—Sunitinib—pancreatic cancer	0.00021	0.000801	CcSEcCtD
Lercanidipine—Dermatitis—Sunitinib—pancreatic cancer	0.00021	0.0008	CcSEcCtD
Lercanidipine—Urticaria—Fluorouracil—pancreatic cancer	0.000209	0.000796	CcSEcCtD
Lercanidipine—Headache—Sunitinib—pancreatic cancer	0.000209	0.000795	CcSEcCtD
Lercanidipine—Syncope—Docetaxel—pancreatic cancer	0.000208	0.000794	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—pancreatic cancer	0.000208	0.000793	CcSEcCtD
Lercanidipine—Pollakiuria—Epirubicin—pancreatic cancer	0.000208	0.000792	CcSEcCtD
Lercanidipine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000208	0.000792	CcSEcCtD
Lercanidipine—Palpitations—Docetaxel—pancreatic cancer	0.000205	0.000783	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000205	0.000783	CcSEcCtD
Lercanidipine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000204	0.000779	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000204	0.000778	CcSEcCtD
Lercanidipine—Cough—Docetaxel—pancreatic cancer	0.000203	0.000773	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000203	0.000773	CcSEcCtD
Lercanidipine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000202	0.000771	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000199	0.000758	CcSEcCtD
Lercanidipine—Arthralgia—Docetaxel—pancreatic cancer	0.000198	0.000754	CcSEcCtD
Lercanidipine—Myalgia—Docetaxel—pancreatic cancer	0.000198	0.000754	CcSEcCtD
Lercanidipine—Chest pain—Docetaxel—pancreatic cancer	0.000198	0.000754	CcSEcCtD
Lercanidipine—Nausea—Sunitinib—pancreatic cancer	0.000198	0.000754	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000198	0.000754	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—pancreatic cancer	0.000197	0.000752	CcSEcCtD
Lercanidipine—Asthenia—Irinotecan—pancreatic cancer	0.000197	0.00075	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000197	0.000749	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000196	0.000749	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—pancreatic cancer	0.000196	0.000745	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—pancreatic cancer	0.000196	0.000745	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—pancreatic cancer	0.000195	0.000742	CcSEcCtD
Lercanidipine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000194	0.000738	CcSEcCtD
Lercanidipine—Dry mouth—Docetaxel—pancreatic cancer	0.000193	0.000738	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000192	0.000733	CcSEcCtD
Lercanidipine—Asthenia—Gemcitabine—pancreatic cancer	0.000192	0.000731	CcSEcCtD
Lercanidipine—Confusional state—Docetaxel—pancreatic cancer	0.000191	0.000729	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00019	0.000724	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00019	0.000723	CcSEcCtD
Lercanidipine—Pruritus—Gemcitabine—pancreatic cancer	0.000189	0.000721	CcSEcCtD
Lercanidipine—Diarrhoea—Irinotecan—pancreatic cancer	0.000188	0.000716	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000187	0.000714	CcSEcCtD
Lercanidipine—Shock—Docetaxel—pancreatic cancer	0.000187	0.000711	CcSEcCtD
Lercanidipine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000186	0.000709	CcSEcCtD
Lercanidipine—Pruritus—Fluorouracil—pancreatic cancer	0.000186	0.000709	CcSEcCtD
Lercanidipine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000186	0.000708	CcSEcCtD
Lercanidipine—Tachycardia—Docetaxel—pancreatic cancer	0.000185	0.000706	CcSEcCtD
Lercanidipine—Skin disorder—Docetaxel—pancreatic cancer	0.000184	0.000702	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000184	0.000701	CcSEcCtD
Lercanidipine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000183	0.000697	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—pancreatic cancer	0.000182	0.000695	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000182	0.000693	CcSEcCtD
Lercanidipine—Dizziness—Irinotecan—pancreatic cancer	0.000181	0.000692	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—pancreatic cancer	0.000181	0.00069	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—pancreatic cancer	0.000181	0.00069	CcSEcCtD
Lercanidipine—Anorexia—Docetaxel—pancreatic cancer	0.000181	0.000689	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—pancreatic cancer	0.000181	0.000688	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—pancreatic cancer	0.00018	0.000686	CcSEcCtD
Lercanidipine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00018	0.000685	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000178	0.000678	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000177	0.000676	CcSEcCtD
Lercanidipine—Hypotension—Docetaxel—pancreatic cancer	0.000177	0.000676	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000177	0.000674	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—pancreatic cancer	0.000177	0.000673	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000176	0.000669	CcSEcCtD
Lercanidipine—Vomiting—Irinotecan—pancreatic cancer	0.000174	0.000665	CcSEcCtD
Lercanidipine—Dizziness—Fluorouracil—pancreatic cancer	0.000174	0.000662	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000173	0.00066	CcSEcCtD
Lercanidipine—Rash—Irinotecan—pancreatic cancer	0.000173	0.000659	CcSEcCtD
Lercanidipine—Dermatitis—Irinotecan—pancreatic cancer	0.000173	0.000659	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000173	0.000659	CcSEcCtD
Lercanidipine—Headache—Irinotecan—pancreatic cancer	0.000172	0.000655	CcSEcCtD
Lercanidipine—Insomnia—Docetaxel—pancreatic cancer	0.000172	0.000654	CcSEcCtD
Lercanidipine—Paraesthesia—Docetaxel—pancreatic cancer	0.00017	0.000649	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—pancreatic cancer	0.00017	0.000649	CcSEcCtD
Lercanidipine—Vomiting—Gemcitabine—pancreatic cancer	0.00017	0.000648	CcSEcCtD
Lercanidipine—Dyspnoea—Docetaxel—pancreatic cancer	0.000169	0.000645	CcSEcCtD
Lercanidipine—Somnolence—Docetaxel—pancreatic cancer	0.000169	0.000643	CcSEcCtD
Lercanidipine—Rash—Gemcitabine—pancreatic cancer	0.000169	0.000642	CcSEcCtD
Lercanidipine—Dermatitis—Gemcitabine—pancreatic cancer	0.000168	0.000642	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—pancreatic cancer	0.000168	0.000641	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—pancreatic cancer	0.000168	0.00064	CcSEcCtD
Lercanidipine—Headache—Gemcitabine—pancreatic cancer	0.000167	0.000638	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000167	0.000637	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—pancreatic cancer	0.000167	0.000637	CcSEcCtD
Lercanidipine—Vomiting—Fluorouracil—pancreatic cancer	0.000167	0.000637	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—pancreatic cancer	0.000167	0.000637	CcSEcCtD
Lercanidipine—Dyspepsia—Docetaxel—pancreatic cancer	0.000167	0.000636	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—pancreatic cancer	0.000167	0.000635	CcSEcCtD
Lercanidipine—Rash—Fluorouracil—pancreatic cancer	0.000166	0.000632	CcSEcCtD
Lercanidipine—Dermatitis—Fluorouracil—pancreatic cancer	0.000166	0.000631	CcSEcCtD
Lercanidipine—Decreased appetite—Docetaxel—pancreatic cancer	0.000165	0.000628	CcSEcCtD
Lercanidipine—Headache—Fluorouracil—pancreatic cancer	0.000165	0.000628	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000165	0.000627	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000164	0.000626	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000164	0.000624	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000164	0.000624	CcSEcCtD
Lercanidipine—Fatigue—Docetaxel—pancreatic cancer	0.000164	0.000623	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—pancreatic cancer	0.000163	0.000623	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000163	0.000623	CcSEcCtD
Lercanidipine—Nausea—Irinotecan—pancreatic cancer	0.000163	0.000621	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—pancreatic cancer	0.000163	0.00062	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000162	0.000619	CcSEcCtD
Lercanidipine—Constipation—Docetaxel—pancreatic cancer	0.000162	0.000618	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—pancreatic cancer	0.000159	0.000607	CcSEcCtD
Lercanidipine—Nausea—Gemcitabine—pancreatic cancer	0.000159	0.000605	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—pancreatic cancer	0.000158	0.000601	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000158	0.0006	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—pancreatic cancer	0.000157	0.000598	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—pancreatic cancer	0.000157	0.000598	CcSEcCtD
Lercanidipine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000156	0.000596	CcSEcCtD
Lercanidipine—Nausea—Fluorouracil—pancreatic cancer	0.000156	0.000595	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—pancreatic cancer	0.000156	0.000594	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—pancreatic cancer	0.000155	0.000592	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000155	0.000591	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000155	0.000589	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—pancreatic cancer	0.000155	0.000589	CcSEcCtD
Lercanidipine—Tension—Epirubicin—pancreatic cancer	0.000154	0.000586	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—pancreatic cancer	0.000153	0.000585	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—pancreatic cancer	0.000152	0.00058	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—pancreatic cancer	0.000151	0.000576	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—pancreatic cancer	0.000151	0.000574	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—pancreatic cancer	0.00015	0.000574	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00015	0.000572	CcSEcCtD
Lercanidipine—Abdominal pain—Docetaxel—pancreatic cancer	0.00015	0.000572	CcSEcCtD
Lercanidipine—Body temperature increased—Docetaxel—pancreatic cancer	0.00015	0.000572	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—pancreatic cancer	0.000148	0.000563	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—pancreatic cancer	0.000147	0.000561	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—pancreatic cancer	0.000146	0.000556	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000145	0.000554	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—pancreatic cancer	0.000145	0.000553	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—pancreatic cancer	0.000145	0.000553	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—pancreatic cancer	0.000145	0.000552	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—pancreatic cancer	0.000142	0.000543	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000142	0.000541	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—pancreatic cancer	0.000141	0.000539	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—pancreatic cancer	0.000141	0.000537	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—pancreatic cancer	0.000141	0.000537	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—pancreatic cancer	0.000141	0.000536	CcSEcCtD
Lercanidipine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00014	0.000533	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000139	0.000532	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—pancreatic cancer	0.000139	0.000528	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000138	0.000525	CcSEcCtD
Lercanidipine—Cough—Epirubicin—pancreatic cancer	0.000137	0.000521	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—pancreatic cancer	0.000137	0.000521	CcSEcCtD
Lercanidipine—Asthenia—Docetaxel—pancreatic cancer	0.000136	0.000519	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000135	0.000513	CcSEcCtD
Lercanidipine—Pruritus—Docetaxel—pancreatic cancer	0.000134	0.000512	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—pancreatic cancer	0.000134	0.000511	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—pancreatic cancer	0.000133	0.000509	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—pancreatic cancer	0.000133	0.000509	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—pancreatic cancer	0.000133	0.000509	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—pancreatic cancer	0.000133	0.000507	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000133	0.000505	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—pancreatic cancer	0.000132	0.000503	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—pancreatic cancer	0.000131	0.000499	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—pancreatic cancer	0.000131	0.000498	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—pancreatic cancer	0.00013	0.000497	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—pancreatic cancer	0.00013	0.000496	CcSEcCtD
Lercanidipine—Diarrhoea—Docetaxel—pancreatic cancer	0.00013	0.000495	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—pancreatic cancer	0.000129	0.000492	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—pancreatic cancer	0.000128	0.000489	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000127	0.000486	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—pancreatic cancer	0.000127	0.000482	CcSEcCtD
Lercanidipine—Shock—Epirubicin—pancreatic cancer	0.000126	0.00048	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000125	0.000478	CcSEcCtD
Lercanidipine—Dizziness—Docetaxel—pancreatic cancer	0.000125	0.000478	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000125	0.000477	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—pancreatic cancer	0.000125	0.000476	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—pancreatic cancer	0.000124	0.000474	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000124	0.000471	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—pancreatic cancer	0.000123	0.000471	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—pancreatic cancer	0.000123	0.000471	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—pancreatic cancer	0.000123	0.000471	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—pancreatic cancer	0.000123	0.000469	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000123	0.000467	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—pancreatic cancer	0.000122	0.000465	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—pancreatic cancer	0.000122	0.000465	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—pancreatic cancer	0.000121	0.00046	CcSEcCtD
Lercanidipine—Vomiting—Docetaxel—pancreatic cancer	0.000121	0.00046	CcSEcCtD
Lercanidipine—Rash—Docetaxel—pancreatic cancer	0.00012	0.000456	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—pancreatic cancer	0.00012	0.000456	CcSEcCtD
Lercanidipine—Dermatitis—Docetaxel—pancreatic cancer	0.000119	0.000455	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—pancreatic cancer	0.000119	0.000455	CcSEcCtD
Lercanidipine—Headache—Docetaxel—pancreatic cancer	0.000119	0.000453	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000117	0.000444	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—pancreatic cancer	0.000116	0.000444	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000116	0.000442	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000116	0.000442	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—pancreatic cancer	0.000116	0.000441	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—pancreatic cancer	0.000116	0.00044	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—pancreatic cancer	0.000115	0.000438	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—pancreatic cancer	0.000115	0.000438	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000114	0.000436	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—pancreatic cancer	0.000114	0.000435	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—pancreatic cancer	0.000114	0.000434	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—pancreatic cancer	0.000113	0.00043	CcSEcCtD
Lercanidipine—Nausea—Docetaxel—pancreatic cancer	0.000113	0.000429	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—pancreatic cancer	0.000113	0.000429	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—pancreatic cancer	0.000111	0.000424	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—pancreatic cancer	0.000111	0.000422	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00011	0.000421	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—pancreatic cancer	0.00011	0.00042	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—pancreatic cancer	0.000109	0.000417	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000108	0.000411	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—pancreatic cancer	0.000107	0.000408	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000106	0.000405	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000106	0.000402	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000105	0.000402	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—pancreatic cancer	0.000105	0.000401	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000105	0.000399	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000104	0.000397	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000103	0.000392	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000102	0.00039	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—pancreatic cancer	0.000102	0.000389	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—pancreatic cancer	0.000102	0.000387	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—pancreatic cancer	0.000101	0.000386	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—pancreatic cancer	0.000101	0.000385	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—pancreatic cancer	0.000101	0.000385	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—pancreatic cancer	9.75e-05	0.000372	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.68e-05	0.000369	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—pancreatic cancer	9.43e-05	0.000359	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—pancreatic cancer	9.4e-05	0.000358	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—pancreatic cancer	9.36e-05	0.000357	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—pancreatic cancer	9.36e-05	0.000357	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—pancreatic cancer	9.18e-05	0.00035	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—pancreatic cancer	9.05e-05	0.000345	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—pancreatic cancer	8.75e-05	0.000334	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—pancreatic cancer	8.72e-05	0.000332	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—pancreatic cancer	8.49e-05	0.000324	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—pancreatic cancer	8.46e-05	0.000322	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—pancreatic cancer	8.37e-05	0.000319	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—pancreatic cancer	8.13e-05	0.00031	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—pancreatic cancer	8.1e-05	0.000309	CcSEcCtD
Lercanidipine—Rash—Epirubicin—pancreatic cancer	8.07e-05	0.000307	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—pancreatic cancer	8.06e-05	0.000307	CcSEcCtD
Lercanidipine—Headache—Epirubicin—pancreatic cancer	8.01e-05	0.000305	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—pancreatic cancer	7.83e-05	0.000298	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—pancreatic cancer	7.6e-05	0.00029	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—pancreatic cancer	7.53e-05	0.000287	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—pancreatic cancer	7.46e-05	0.000284	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—pancreatic cancer	7.46e-05	0.000284	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—pancreatic cancer	7.42e-05	0.000283	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—pancreatic cancer	7.03e-05	0.000268	CcSEcCtD
